Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 2, 1998, Pages 162-170

  Nishanian, Parunag ^a,b   Taylor, Jeremy M G ^c,d   Manna, Byomkesh ^a,c   Aziz, Najib ^a   Grosser, Stella ^c   Giorgi, Janis V ^b,d   Detels, Roger ^c,d   Fahey, John L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Los Angeles Center   (United States)

Author keywords

AIDS; CD4+; CD8+ T cells; Inflection points; Neopterin; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; NEOPTERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; HELPER CELL; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0032104043     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199806010-00008     Document Type: Article

References (47)

1. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993;262:1011-18.
2. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-72.
3. Ascher MS, Sheppard HW. AIDS as immune system activation. II. The panergic amnesia hypothesis. J Acquir Immune Defic Syndr 1990;3:177-91.
4. Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev 1994;7:14-28.
5. Kramer A, Biggar RA, Hampl H, Fuchs D, Goedert JJ. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am J Epidemiol 1992;136:71-80.
6. Pantaleo G, Graziosi C, Fauci A. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328: 327-35.
7. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
8. H2 predominance in HIV-infected individuals. Science 1994;265:248-52.
9. Moss AR, Bacchetti P, Osmand D, et al. Seropositivity for HIV and the development of AIDS with AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ 1988;296:745-50.
10. Hofmann B, Wang Y, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. β2-microglobulin level increases in HIV infection: relation to seroconversion. CD4 T-cell fall and prognosis. AIDS 1990;4:207-14.
11. Fuchs D, Spira TJ, Hausen A, et al. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem 1989;35:1746-9.
12. Melmed RN, Taylor JM, Detels R, Bozorgmehri M, Fahey JL. Serum neopterin changes in HIV-infected subjects; indicator of significant pathology, CD4 T cell change, and the development of AIDS. J Acquir Immune Defic Syndr 1989;2:70-6.
13. Sheppard HW, Ascher MS, McRae B, Anderson RE, Lang W, Allain JP. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr 1991;4:704-12.
14. Shi M, Taylor JMG, Fahey JL, et al. Early levels of CD4, neopterin and β2-microglobulin indicate further disease progression. J Clin Immunol 1997;17:43-52.
15. Phair JP. Keynote address: variations in the natural history of HIV infection. AIDS Res Hum Retroviruses 1994;10:883-5.
16. + T cell levels. AIDS 1993;7:1159-66.
17. Haynes BF, Pantaleo G, Fauci AS. Towards an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-8.
18. Detels R, English AP, Giorgi JV, et al. Patterns of CD4- cell changes after HIV-1 infection indicate the existence of codeterminant of AIDS. J Acquir Immune Defic Syndr 1988;1:390-5.
19. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991;337:389-92.
20. Lange L, Carlin BP, Gelfand AE. Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers. J Am Stat Assoc 1992;87:615-26.
21. DeGruttola V, Lang N, Dafni U. Modeling the progression of HIV-1 infection. J Am Stat Assoc 1991;86:569-77.
22. Taylor JMG, Cumberland WG, Sy JP. A stochastic model for analysis of longitudinal AIDS data. J Am Stat Assoc 1994;89:727-36.
23. Kiuchi AS, Hartigan JA, Holford TR, Rubinstein P, Stevens CE. Change points in the series of T4 counts prior to AIDS. Biometrics 1995;51:236-48.
24. Galai N, Muñoz A, Chen K, Carey VJ, Chmiel J, Zhou SYJ. Tracking of markers and onset of disease among HIV-1 seroconverters. Stat Med 1993;12:2133-45.
25. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W. Jr. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989;2:63-9.
26. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry M, Goedert JJ. Natural history of human immunodeficiency virus infection on hemophiliacs: effects of T-cell subsets, platelet counts and age. Ann Intern Med 1987;107:1-6.
27. Burcham J, Marmor M, Dubin N, et al. CD4% is the best predictor of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5:365-72.
28. + and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. J Acquir Immune Defic Syndr 1993;6:153-61.
29. Margolick JB, Muñoz A, Donnenberg AD, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1995;1:674-80.
30. Galai N, Margolick JB, Astemborski J, Vlahov D. Existence and failure of T cell homeostasis prior to AIDS onset in HIV infected injection drug users. Clin Immunol Immunopathol 1996;79:134-41.
31. Adelman LM, Wofsy D. T-cell homeostasis: implications in HIV infection. J Acquire Immune Defic Syndr 1993;6:144-52.
32. Nishanian P, Aziz N, Taylor JMG, Detels R, Fahey JL. Identification of an inclination point for progression to AIDS [abstract]. International Symposium on Clinical Immunology, San Francisco, 1995.
33. Nishanian P, Taylor JMG, Manna B, et al. Inflection points for CD4, CD8 and CD3 T cell levels and immune activation markers prior to AIDS onset. Immunologist 1997;5(Suppl 1):4.
34. Kaslow RA, Ostow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The multicenter AIDS cohort study: rationale, organization and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-18.
35. Nishanian P, Taylor JM, Korns E, Detels R, Saah A, Fahey JL. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J Clin Microbiol 1987;25:395-400.
36. Schenker EL, Hultin LE, Bauer KD, et al. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 1993;14:307-17.
37. Salazar-Gonzalez JF, Martinez-Maza O, Nishanian PG, et al. Dysregulated cytokine kinetics prior to AIDS [abstract]. XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
38. Goulder PJR, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212-17.
39. + T cells in HIV-infected homosexual men [abstract]. XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
40. + cell inflection and HIV heterogeneity [abstract]. XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
41. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988;9: 150-5.
42. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160: 310-16.
43. Hofmann B, Bass H, Nishanian P, et al. Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumor necrosis factor-alpha. Clin Exp Immunol 1992; 88:548-54.
44. Aukrust P, Liabakk N-B, Müller F, Lien E, Espevik T, Frøland SS. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic and virologic parameters. J Infect Dis 1994;169:420-4.
45. H2 cytokine in HIV infection. Immunol Rev 1994;140:73-92.
46. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991;5: 1405-17.
47. Zangerle R, Gallati H, Sarcletti M, et al. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 1994;7:79-85.